MENA Generic Oncology Drug Market, Growth, Size, Share, Trends and forecast (2024-2032)
According to a new report by UnivDatos, the “MENA Generic Oncology Drug Market” is expected to reach USD 7.5 Billion in 2032 by growing at a CAGR of 3%. The Middle East and North Africa (MENA) region is witnessing a notable surge in the demand for oncology drugs, driven by the increasing prevalence of cancer and the need for affordable treatment options. Within this landscape,...
0 Kommentare 0 Geteilt 10 Ansichten